Gastroenterology
-
Colorectal cancer treatment delayed for up to a year
Some patients with colorectal cancer do not begin treatment until a year after they first notice symptoms, researchers warn today. Read more
-
Common substances may reduce bowel polyp risk
Both aspirin and fish oil can improve the prospects for people at high risk of developing bowel cancer, according to the findings of a major UK study published today. Read more
-
Drug combination for neuroblastoma?
A new drug combination has shown “highly significant” results in laboratory tests on neuroblastoma, a European conference will hear today. Read more
-
HER2 cancers respond well to new drug
People with cancers of the oesophagus, stomach and colon have experienced positive results from a new anti-HER2 drug, a European conference is being told today. Read more
-
Appendix a source of Parkinson’s?
People who have undergone appendectomy as children face a reduced risk of developing Parkinson’s disease, according to the findings of a major study in Sweden. Read more
-
Obesity link to early antibiotics
Children who are given antibiotics and antacids in early life may face an increased risk of becoming obese, researchers warn today. Read more
-
Antibiotics, the ‘avoidable trigger’ for bowel disease
A high fibre diet should be followed when taking antibiotics because the drugs can predispose the gut to avoidable infections that trigger bowel disease in mice. Read more
-
New stem cell trial for Crohn’s patients
A new UK trial is to test the use of stem cell transplants to grow new immune systems for people with untreatable Crohn’s disease, was announced today. Read more
-
Bowel screening may reveal other diseases
The UK screening programme for bowel cancer may be identifying people at risk from a range of other diseases, researchers say today. Read more
-
Antifungal drug could halt dormant bowel cancer cells
A treatment used for toenail problems could be used to help eliminate dormant cells within bowel tumours, new research has unveiled. Read more